4//SEC Filing
Corcoran Gavin 4
Accession 0001636050-21-000029
CIK 0001636050other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 4:58 PM ET
Size
11.2 KB
Accession
0001636050-21-000029
Insider Transaction Report
Form 4
Corcoran Gavin
EVP of R&D
Transactions
- Award
Common Stock
2021-03-17+16,001→ 25,792 total - Disposition to Issuer
Restricted Stock Units
2021-03-17−16,001→ 0 total→ Common Stock (16,001 underlying)
Footnotes (1)
- [F1]Each restricted stock unit represents the right to receive one share of the Issuer's common stock. The shares of common stock underlying the restricted stock units vested on July 31, 2020 but settlement of the restricted stock units was delayed until transactions acceptable under the Issuer's insider trading policy were permitted.
Issuer
Sio Gene Therapies Inc.
CIK 0001636050
Entity typeother
Related Parties
1- filerCIK 0001745995
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 4:58 PM ET
- Size
- 11.2 KB